Tumor heterogeneity impairs robustness of Ki67 scoring in breast cancer

被引：0
|
作者：
Nijenhuis, Matthijs V. [1 ]
Groen, Emilie [1 ]
Dekker, Tim J. [2 ]
Drukker, Caroline A. [1 ]
Sanders, J. [1 ]
Smit, V. T. [2 ]
Linn, S. [1 ]
Rutgers, E. J. [1 ]
Wesseling, J. [1 ]
机构：
[1] Antoni van Leeuwenhoek, Amsterdam, Netherlands
[2] Leiden Univ, Med Ctr, NL-2300 RA Leiden, Netherlands
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.SABCS14-P5-02-04
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-02-04
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Impact of tumour heterogeneity on the robustness of Ki67 scoring in breast cancer
    Nijenhuis, M. V.
    Drukker, C. A.
    Sanders, J.
    Linn, S. C.
    Rutgers, E. J. T.
    Wesseling, J.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S194 - S194
  • [2] The Ki67 dilemma: investigating prognostic cut-offs and reproducibility for automated Ki67 scoring in breast cancer
    Rewcastle, Emma
    Skaland, Ivar
    Gudlaugsson, Einar
    Fykse, Silja Kavlie
    Baak, Jan P. A.
    Janssen, Emiel A. M.
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 207 (01) : 1 - 12
  • [3] Prognostic Significance of the Ki67 Scoring Categories in Breast Cancer Subgroups
    Niikura, Naoki
    Masuda, Shinobu
    Kumaki, Nobue
    Tang Xiaoyan
    Terada, Mizuho
    Terao, Mayako
    Iwamoto, Takayuki
    Oshitanai, Risa
    Morioka, Toru
    Tuda, Banri
    Okamura, Takuho
    Saito, Yuki
    Suzuki, Yasuhiro
    Tokuda, Yutaka
    CLINICAL BREAST CANCER, 2014, 14 (05) : 323 - 329
  • [4] Impact of intratumoural heterogeneity on the assessment of Ki67 expression in breast cancer
    Aleskandarany, M. A.
    Green, A. R.
    Ashankyty, I.
    Elmouna, A.
    Diez-Rodriguez, M.
    Nolan, C. C.
    Ellis, I. O.
    Rakha, E. A.
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 158 (02) : 287 - 295
  • [5] Impact of intratumoural heterogeneity on the assessment of Ki67 expression in breast cancer
    M. A. Aleskandarany
    A. R. Green
    I Ashankyty
    A Elmouna
    M Diez-Rodriguez
    C. C. Nolan
    I. O. Ellis
    E. A. Rakha
    Breast Cancer Research and Treatment, 2016, 158 : 287 - 295
  • [6] Independent Clinical Validation of the Automated Ki67 Scoring Guideline from the International Ki67 in Breast Cancer Working Group
    Boyaci, Ceren
    Sun, Wenwen
    Robertson, Stephanie
    Acs, Balazs
    Hartman, Johan
    BIOMOLECULES, 2021, 11 (11)
  • [7] Ki67 and proliferation in breast cancer
    Pathmanathan, Nirmala
    Balleine, Rosemary L.
    JOURNAL OF CLINICAL PATHOLOGY, 2013, 66 (06) : 512 - 516
  • [8] Automated computational Ki67 scoring in the GeparTrio breast cancer study cohort
    Klauschen, F.
    Wienert, S.
    Blohmer, J-U
    Mueller, B. M.
    Eiermann, W.
    Gerber, B.
    Tesch, H.
    Hilfrich, J.
    Huober, J.
    Fehm, T.
    Barinoff, J.
    Jackisch, C.
    Erbstoesser, E.
    Loibl, S.
    Denkert, C.
    von Minckwitz, G.
    CANCER RESEARCH, 2012, 72
  • [9] Manual vs Digital Scoring of Ki67 in Breast Cancer; A Validation Study
    Siddiqi, Ahsan
    Geiger, Xochiquetzal
    Majewicz, Tracy
    Nassar, Aziza
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1489 - 1490
  • [10] Manual vs Digital Scoring of Ki67 in Breast Cancer; A Validation Study
    Siddiqi, Ahsan
    Geiger, Xochiquetzal
    Majewicz, Tracy
    Nassar, Aziza
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1489 - 1490
12345